PGS: Pre-Implantation Genetic Testing (Embryo) - 9

What is PGS Embryo 9?

Preimplantation Genetic Screening (PGS) Embryo 9 is a specialized test performed on embryos created via in vitro fertilization (IVF) to check for numerical chromosome abnormalities before implantation.


Why is this test performed?

PGS is conducted to improve the chances of a successful pregnancy by ensuring only embryos with a normal chromosomal count are implanted. It is particularly beneficial for couples with a history of recurrent miscarriages, advanced maternal age, or known chromosomal translocations.


How is the test performed?

A few cells are biopsied from the developing embryo on day five or six after fertilization. These cells undergo genetic analysis using techniques like next-generation sequencing (NGS) to determine chromosomal integrity.


What do the results indicate?

A normal embryo is more likely to result in a successful pregnancy, while an abnormal result suggests chromosomal defects that could lead to implantation failure or miscarriage.


What happens after receiving the test results?

Based on the results, the healthiest embryo is selected for transfer, improving the likelihood of a successful pregnancy and reducing the risk of chromosomal disorders.